These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8013029)

  • 21. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
    Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
    J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis.
    Van Lierde J; De Geest H; Verstraete M; Van de Werf F
    J Am Coll Cardiol; 1990 Dec; 16(7):1545-9. PubMed ID: 2123904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)].
    Gulba DC; Bode C; Topp J; Höpp HW; Westhoff-Bleck M; Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1990 Apr; 79(4):279-85. PubMed ID: 2113330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of local intracoronary fibrinolysis in acute myocardial infarct and the effects of reperfusion on the function of the left ventricle].
    Müller JH; Weser C; Anders G; Kumm KP; Brunke W; Heinrichs C
    Z Gesamte Inn Med; 1984 Dec; 39(23):573-8. PubMed ID: 6528681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy.
    Bolognese L; Sarasso G; Bongo AS; Rossi L; Aralda D; Piccinino C; Rossi P
    Circulation; 1991 Sep; 84(3):1100-6. PubMed ID: 1884442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and angiographic features of patients with an occluded versus a patent infarct vessel after intravenous streptokinase for acute myocardial infarction.
    Chouhan L; Hajar HA; George T; Pomposiello JC
    Angiology; 1993 Jun; 44(6):425-31. PubMed ID: 8503507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group.
    Weaver WD; Hartmann JR; Anderson JL; Reddy PS; Sobolski JC; Sasahara AA
    J Am Coll Cardiol; 1994 Nov; 24(5):1242-8. PubMed ID: 7930246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
    J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA; Muller DW; Topol EJ
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prognosis of patency of infarct-related coronary artery after thrombolytic treatment in acute myocardial infarction. Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Mar; 110(3):191-4. PubMed ID: 9594338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late clinical and angiographic follow-up after stenting in evolving and recent myocardial infarction.
    Le May MR; Labinaz M; Marquis JF; O'Brien ER; Beanlands RS; Laramée LA; Williams WL; Davies RF; Kearns SA; Higginson LA
    Am Heart J; 1998 Apr; 135(4):714-8. PubMed ID: 9539491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
    Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ
    Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Califf RM; Ellis SG; Sigmon KN; Lee KL; Leimberger JD; Topol EJ
    J Am Coll Cardiol; 1993 Dec; 22(7):1780-7. PubMed ID: 8245328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The late open artery hypothesis at the crossroad. The ACTOR study: aggressive versus conservative treatment of the infarct-related artery after acute MI. ACTOR Study Group.
    G Ital Cardiol; 1999 Jan; 29(1):1-10. PubMed ID: 9987041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial.
    Lehmann KG; Francis CK; Sheehan FH; Dodge HT
    J Am Coll Cardiol; 1993 Sep; 22(3):714-9. PubMed ID: 8354803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Residual coronary artery stenosis: its shapes immediately after thrombolysis and subsequent time courses].
    Kijima M; Matsumoto S; Ikeda K; Ohwada K; Kariyone S
    J Cardiol; 1989 Jun; 19(2):393-402. PubMed ID: 2636621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.
    Denardo SJ; Morris NB; Rocha-Singh KJ; Curtis GP; Rubenson DS; Teirstein PS
    Am J Cardiol; 1995 Oct; 76(11):776-80. PubMed ID: 7572653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.